Title: Effects on bladder function of combining elocalcitol and tolterodine in rats with outflow obstruction.
Journal: BJU international 20120701
Title: Phase IIb, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to determine effects of elocalcitol in women with overactive bladder and idiopathic detrusor overactivity.
Journal: Urology 20120701
Title: Human prostatic urethra expresses vitamin D receptor and responds to vitamin D receptor ligation.
Journal: Journal of endocrinological investigation 20101101
Title: Comparison between VDR analogs and current immunosuppressive drugs in relation to CXCL10 secretion by human renal tubular cells.
Journal: Transplant international : official journal of the European Society for Organ Transplantation 20100901
Title: Chronic inflammation in the pathogenesis of benign prostatic hyperplasia.
Journal: International journal of andrology 20100601
Title: Elocalcitol, a vitamin D3 analog for the potential treatment of benign prostatic hyperplasia, overactive bladder and male infertility.
Journal: IDrugs : the investigational drugs journal 20090601
Title: The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
Journal: The Prostate 20090401
Title: Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells.
Journal: Endocrinology 20080701
Title: The vitamin D receptor agonist elocalcitol upregulates L-type calcium channel activity in human and rat bladder.
Journal: American journal of physiology. Cell physiology 20080501
Title: Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway.
Journal: Journal of andrology 20080101
Title: Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol).
Journal: The Journal of steroid biochemistry and molecular biology 20070301
Title: BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder.
Journal: The Prostate 20070215
Title: Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20061215
Title: Effects of a vitamin D(3) analogue in a rat model of bladder outlet obstruction.
Journal: BJU international 20060901
Title: The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells.
Journal: Journal of cancer research and clinical oncology 20060601
Title: Non-genomic effects of the androgen receptor and vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells.
Journal: Steroids 20060401
Title: Oral treatment with a vitamin D3 analogue (BXL628) has anti-inflammatory effects in rodent model of interstitial cystitis.
Journal: BJU international 20060301
Title: Emerging drug therapies for benign prostatic hyperplasia.
Journal: Expert opinion on emerging drugs 20060301
Title: BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial.
Journal: European urology 20060101
Title: Pre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol).
Journal: Journal of endocrinological investigation 20060101
Title: Inhibition of acute and chronic allograft rejection in mouse models by BXL-628, a nonhypercalcemic vitamin D receptor agonist.
Journal: Transplantation 20050715
Title: Human bladder as a novel target for vitamin D receptor ligands.
Journal: The Journal of clinical endocrinology and metabolism 20050201
Title: Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia.
Journal: European journal of endocrinology 20040401
Title: Cellular and molecular events associated with the bone-protecting activity of the noncalcemic vitamin D analog Ro-26-9228 in osteopenic rats.
Journal: Endocrinology 20020501
